Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
A.forall Launches Generic Tromethamine With 180-Day US Exclusivity
Launch Marks The Second A.forall Product With The Coveted CGT Designation
Feb 05 2025
•
By
Adam Zamecnik
Teva has settled with “all 50 states and 99% of litigating subdivisions” • Source: Shutterstock
More from Business
More from Generics Bulletin